Terazosin - CAS 63590-64-7

Terazosin, a quinazoline derivative, is an orally active and competitive antagonist of α1-adrenoceptors. Its mechanism of action involves relaxing blood vessels and promoting bladder opening. Terazosin exhibits therapeutic potential for treating benign prostatic hyperplasia (BPH) and high blood pressure [1][2][3].

Others, Adrenergic Receptor

Neuroscience, Others, GPCR/G Protein

63519

C19H25N5O4

387.43

NC=1C2=C(N=C(N1)N3CCN(C(=O)C4CCCO4)CC3)C=C(OC)C(OC)=C2

-20°C

Ice Packs

Small Compound